NeoStem proposes follow-on

NeoStem Inc. (NYSE-A:NBS), New York, N.Y. Business: Gene/Cell therapy, Supply/Service Date announced: 12/15/09 Type: Follow-on To be raised: TBD Shares: 17.3 million Price prior: $1.65 Underwriters: R...